OFFICIAL PUBLICATION OF

by its subsidiary APPco

Price reduction for combinations

Chris Brooker 02/08/2016

A range of combination medicines are due to experience price cuts in the 1 October round of price disclosure measures.The newly advised cuts will affect combination drugs due to experience flow-on price reductions.The 2015 Access and Sustainability amendments to the National Health Act 1953 provide for price disclosure reductions to component drugs to be flowed-on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘Consumer confusion, pharmacist frustration’ if current system continues

I welcome Mark's move, at least someone talks about it. But like any push at the forefront, it comes with…

Benjamyn Sung

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Price reduction for combinations

Previous Sore throat and sinusitis, and the few benefits of antibiotics

Next HMR caps still a concern

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Sore throat and sinusitis, and the few benefits of antibiotics

Next HMR caps still a concern

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.